Found: 31
Select item for more details and to access through your institution.
Improved health perception after genetic counselling for women at high risk of breast and/or ovarian cancer: construction of new questionnaires-an Italian exploratory study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 3, p. 633, doi. 10.1007/s00432-015-2062-7
- By:
- Publication type:
- Article
CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
“Burned out” phenomenon of the testis in retroperitoneal seminoma.
- Published in:
- 2006
- By:
- Publication type:
- Letter
The new era of immune checkpoint inhibition and target therapy in early-stage non-small cell lung cancer. A review of the literature.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 2, p. 108, doi. 10.1016/j.cllc.2021.11.003
- By:
- Publication type:
- Article
Reply.
- Published in:
- 2020
- By:
- Publication type:
- Letter
ROS1-rearranged Non-small-cell Lung Cancer is Associated With a High Rate of Venous Thromboembolism: Analysis From a Phase II, Prospective, Multicenter, Two-arms Trial (METROS).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Activity of EGFR TKIs in Caucasian Patients With NSCLC Harboring Potentially Sensitive Uncommon EGFR Mutations.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Dramatic Antitumor Activity of Nivolumab in Advanced HER2-Positive Lung Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
"Waiting and the waiting room: how do you experience them?" emotional implications and suggestions from patients with cancer.
- Published in:
- 2011
- By:
- Publication type:
- journal article
'Waiting and the Waiting Room: How Do You Experience Them?' Emotional Implications and Suggestions from Patients with Cancer.
- Published in:
- Journal of Cancer Education, 2011, v. 26, n. 2, p. 388, doi. 10.1007/s13187-010-0057-2
- By:
- Publication type:
- Article
Lung Tissue Injury as an Atypical Response to Nivolumab in Non-Small Cell Lung Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Co-Occurring Driver Genomic Alterations in Advanced Non-Small-Cell Lung Cancer (NSCLC): A Retrospective Analysis.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 15, p. 4476, doi. 10.3390/jcm13154476
- By:
- Publication type:
- Article
Non-Small-Cell Lung Cancers (NSCLCs) Harboring RET Gene Fusion, from Their Discovery to the Advent of New Selective Potent RET Inhibitors: "Shadows and Fogs".
- Published in:
- Cancers, 2024, v. 16, n. 16, p. 2877, doi. 10.3390/cancers16162877
- By:
- Publication type:
- Article
Post-Progression Analysis of EGFR -Mutant NSCLC Following Osimertinib Therapy in Real-World Settings.
- Published in:
- Cancers, 2024, v. 16, n. 14, p. 2589, doi. 10.3390/cancers16142589
- By:
- Publication type:
- Article
Alectinib vs. Lorlatinib in the Front-Line Setting for ALK-Rearranged Non-Small-Cell Lung Cancer (NSCLC): A Deep Dive into the Main Differences across ALEX and CROWN Phase 3 Trials.
- Published in:
- Cancers, 2024, v. 16, n. 13, p. 2457, doi. 10.3390/cancers16132457
- By:
- Publication type:
- Article
New Generations of Tyrosine Kinase Inhibitors in Treating NSCLC with Oncogene Addiction: Strengths and Limitations.
- Published in:
- Cancers, 2023, v. 15, n. 20, p. 5079, doi. 10.3390/cancers15205079
- By:
- Publication type:
- Article
MET in Non-Small-Cell Lung Cancer (NSCLC): Cross 'a Long and Winding Road' Looking for a Target.
- Published in:
- Cancers, 2023, v. 15, n. 19, p. 4779, doi. 10.3390/cancers15194779
- By:
- Publication type:
- Article
Association between Contrast-Enhanced Computed Tomography Radiomic Features, Genomic Alterations and Prognosis in Advanced Lung Adenocarcinoma Patients.
- Published in:
- Cancers, 2023, v. 15, n. 18, p. 4553, doi. 10.3390/cancers15184553
- By:
- Publication type:
- Article
Health-Related Quality of Life in Patients with Hormone Refractory Prostate Cancer Receiving Gefitinib.
- Published in:
- Urologia Internationalis, 2009, v. 82, n. 2, p. 196, doi. 10.1159/000200800
- By:
- Publication type:
- Article
Absence of epidermal growth factor receptor gene mutations in patients with hormone refractory prostate cancer not responding to gefitinib.
- Published in:
- Prostate, 2007, v. 67, n. 6, p. 603, doi. 10.1002/pros.20530
- By:
- Publication type:
- Article
Safety, Tolerability and Biological Effects of Long-Term Metronomic Administration of Non-Cytotoxic Anti-Angiogenic Agents.
- Published in:
- Oncology, 2010, v. 77, n. 6, p. 358, doi. 10.1159/000275830
- By:
- Publication type:
- Article
Phase Ib of Sorafenib in Combination With Everolimus in Patients With Advanced Solid Tumors, Selected on the Basis of Molecular Targets.
- Published in:
- Oncologist, 2014, v. 19, n. 4, p. 344, doi. 10.1634/theoncologist.2013-0335
- By:
- Publication type:
- Article
Comparison of real-world data (RWD) analysis on efficacy and post-progression outcomes with pembrolizumab plus chemo vs chemo alone in metastatic non-squamous non-small cell lung cancer with PD-L1 < 50%.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.980765
- By:
- Publication type:
- Article
The Evolving Scenario of ES-SCLC Management: From Biology to New Cancer Therapeutics.
- Published in:
- Genes, 2024, v. 15, n. 6, p. 701, doi. 10.3390/genes15060701
- By:
- Publication type:
- Article
Personalized treatment in advanced ALK-positive non-small cell lung cancer: from bench to clinical practice.
- Published in:
- OncoTargets & Therapy, 2016, v. 9, p. 6361, doi. 10.2147/OTT.S98347
- By:
- Publication type:
- Article
Inactivity of imatinib in gastrointestinal stromal tumors (GISTs) harboring a KIT activation-loop domain mutation (exon 17 mutation pN822K).
- Published in:
- OncoTargets & Therapy, 2015, v. 8, p. 1997, doi. 10.2147/OTT.S81558
- By:
- Publication type:
- Article
Antitumor activity of sorafenib and imatinib in a patient with thymic carcinoma harboring c-KIT exon 13 missense mutation K642E.
- Published in:
- OncoTargets & Therapy, 2014, v. 7, p. 697, doi. 10.2147/OTT.S58902
- By:
- Publication type:
- Article
Fears and Perception of the Impact of COVID-19 on Patients With Lung Cancer: A Mono-Institutional Survey.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.584612
- By:
- Publication type:
- Article
Results of Multilevel Containment Measures to Better Protect Lung Cancer Patients From COVID-19: The IEO Model.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. 1, doi. 10.3389/fonc.2020.00665
- By:
- Publication type:
- Article
Management of Non-Metastatic Non-Small Cell Lung Cancer (NSCLC) with Driver Gene Alterations: An Evolving Scenario.
- Published in:
- Current Oncology, 2024, v. 31, n. 9, p. 5121, doi. 10.3390/curroncol31090379
- By:
- Publication type:
- Article
Sustained Improvement in the Management of Patients with Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocation: Where Are We Running?
- Published in:
- Current Oncology, 2023, v. 30, n. 5, p. 5072, doi. 10.3390/curroncol30050384
- By:
- Publication type:
- Article